Section Arrow
ZLAB.NASDAQ
- Zai Lab Limited
Quotes are at least 15-min delayed:2025/08/31 20:21 EDT
Regular Hours
Last
 33.1
+0.88 (+2.73%)
Day High 
33.51 
Prev. Close
32.22 
1-M High
41.2 
Volume 
378.29K 
Bid
32.61
Ask
33.35
Day Low
32.59 
Open
32.59 
1-M Low
31.79 
Market Cap 
3.59B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 34.25 
20-SMA 35.21 
50-SMA 35.72 
52-W High 44.34 
52-W Low 18.91 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.00/-0.24
Enterprise Value
3.60B
Balance Sheet
Book Value Per Share
7.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
398.99M
Operating Revenue Per Share
2.37
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics0.215-0.013-5.70%-- 
TNFATNF Pharmaceuticals Inc.0.0483-0.0133-21.59%-- 
ADAPAdaptimmune Therapeutics plc0.0589-0.01-14.51%-- 
SRPTSarepta Therapeutics18.2-0.14-0.76%15.76PE
OTLKOutlook Therapeutics0.8512-0.2388-21.91%0.58PE
Quotes are at least 15-min delayed:2025/08/31 20:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.